Cis-regulatory variation is considered to be an important determinant of human phenotypic variability, including susceptibility to complex disease. Recent studies have shown that the effects of cis-regulatory polymorphism on gene expression can differ widely between tissues. In the present study, we tested whether the effects of cis-regulatory variation can also differ between regions of the adult human brain. We used relative allelic expression to measure cis-effects on the RNA expression of 5 candidate genes for neuropsychiatric illness (ZNF804A, NOS1, RGS4, AKT1 and TCF4) across multiple discrete brain regions within individual subjects. For all 5 genes, we observed significant differences in allelic expression between brain regions in several individual subjects, suggesting regional differences in the effects of cisregulatory polymorphism to be a common phenomenon. As well as highlighting an important caveat for studies of regulatory polymorphism in the brain, our findings indicate that it is possible to delineate brain areas in which cis-regulatory variants are active. This may provide important insight into the fundamental biology of neuropsychiatric phenotypes with which such variants are associated. by guest on November 4, 2016 http://hmg.oxfordjournals.org/ Downloaded from
INTRODUCTION
Effects on gene expression can be classified according to whether they originate from the same DNA molecule as the regulated gene or from a remote source, the former said to be acting in cis, and the latter in trans. Variable cis-effects on gene expression can occur as a result of differences in DNA sequence or epigenetic modification at cis-regulatory elements (e.g. promoters, enhancers, locus control regions) distributed at the gene locus, as well as through DNA variation affecting the stability or splicing of the gene product. Such variation is common in the human genome [1] [2] [3] and likely to be an important determinant of phenotypic diversity, including susceptibility to complex disease. Trans-regulatory variation results from differences in the level or structure of trans-acting factors (e.g. transcription factors, hormones, microRNAs), that are usually transcribed at distinct gene loci and subject to similar regulation.
Whereas trans-acting influences operate on both chromosomal gene copies, cis-acting effects on gene expression operate in an allele-specific manner. This difference is exploited in assays of relative allelic expression, where the effects of cis-regulatory variants are exposed by comparing the level of mRNA transcribed from the two chromosomal gene copies in individual samples [1] [2] [3] [4] . The relative allelic expression method typically makes use of a single nucleotide polymorphism (SNP) within the mRNA sequence, allowing the RNA transcribed from each chromosome to be distinguished and quantified in heterozygous subjects. Significant departure from the genomic 1:1 ratio of the two alleles in cDNA is assumed to reflect heterozygosity for one or more cis-regulatory DNA variants or an allele-specific epigenetic process (e.g.
imprinting) operating in the assayed sample. (BA19), temporal cortex (BA21), parietal cortex (BA40), amygdala, hippocampus, thalamus, hypothalamus, nucleus accumbens, caudate, substantia nigra and cerebellum. Relative allelic expression was used to assay for regional differences in cis-regulatory effects in 8 of these subjects for ZNF804A, 11 for RGS4, 5 for AKT1, 5
for NOS1 and 7 for TCF4.
Of the 8 subjects assayed for ZNF804A, 6 showed significant (p < 0.05) differences in cDNA allele ratios between brain regions ( Table 1 ). Levels of significance survived correction for 8 separate tests in 3 of these subjects. Allelic expression imbalance (AEI) was most pronounced in the hippocampus from 2 of these subjects and in the nucleus accumbens in the third. For all 3 subjects, there was at least 1 brain region where cDNA allele ratios were found to average within 5% of the average genomic DNA (1:1) allele ratio, suggesting little or no effect of the assumed cis-regulatory variant(s) in those regions. Repeat assays using freshly-synthesised cDNA confirmed significant (p < 0.05) differences in allele ratios between the region showing most pronounced AEI and the region showing least AEI for all 3 subjects.
When ZNF804A allelic expression data from all regions and from all subjects were considered together, there was found to be a general over-expression of the A-allele of the assayed SNP rs12476147 relative to the T-allele (p < 0.0001), suggesting linkage disequilibrium with a functional regulatory variant. This is consistent with a recent study 12 that showed significant relative over-expression of the G-allele of another exonic ZNF804A SNP, rs4667001, with which the A-allele of rs12476147 is predicted to be consistently in phase (the two SNPs have an r 2 of 1 in the HapMap CEU sample). We therefore performed a further analysis of ZNF804A allelic expression by guest on November 4, 2016 http://hmg.oxfordjournals.org/ Downloaded from 6 across brain regions in which we considered average allelic ratios from all 8 assayed subjects together (data shown in Figure 1 ). This analysis showed a general trend for a difference in ZNF804A allelic expression between assayed brain regions (Kruskal Wallis χ2 = 16.5, d.f. = 9, p = 0.056). We therefore compared cDNA allele ratios from each brain region with genomic DNA allele ratios from all subjects using separate Mann-Whitney tests. Significant (p < 0.05) differences between cDNA and genomic DNA ratios were observed in the temporal cortex, parietal cortex, amygdala, hippocampus, nucleus accumbens and caudate, of which all but the temporal cortex survived Bonferroni correction for 10 tests. Differences between genomic DNA and cDNA allele ratios were most significant in the hippocampus (p = 0.00005, uncorrected), while cDNA allele ratios in the substantia nigra averaged very close to the 1:1 genomic ratio (average allele ratio = 0.996, p = 0.89 uncorrected).
Of the 11 individuals assayed for RGS4, 4 showed significant (p < 0.05) differences in allelic expression between brain regions ( Table 2 ). Levels of significance survived correction for 11 separate tests in 2 of these subjects (#2 and #18). The RGS4 allele that was over-expressed differed between the 2 subjects, suggesting multiple cisregulatory variants and / or incomplete linkage disequilibrium between these variants and the exonic SNP used to measure relative allelic expression. Significant (p < 0.001) differences in cDNA allele ratios between the nucleus accumbens and parietal cortex were confirmed in subject #18 using freshly-synthesised cDNA. Depletion of RNA precluded similar confirmatory assays for subject #2.
Of the 5 subjects assayed for AKT1, 3 showed significant (p < 0.05) differences in cDNA allele ratios between brain regions ( Table 3 ). The significance of all 3 7 observations survived correction for 5 separate tests. Only for one of these subjects (#4) did repeat assays using new cDNA confirm significant differences in allelic expression between the region showing the highest and the region showing least AEI (in this case, cerebellum and hippocampus, respectively).
All 5 subjects assayed for NOS1 showed significant (p < 0.05) differences in allelic expression between brain regions ( Table 4 ). Levels of significance survived correction for 5 separate tests in 3 of these individuals. Repeat assays using freshly synthesised cDNA confirmed significant (p < 0.05) differences in cDNA allele ratios between the parietal cortex and caudate in subject #2 and the temporal cortex and substantia nigra in subject #22. All 7 subjects assayed for TCF4 showed significant (p < 0.05) differences in allelic expression between brain regions, with levels of significance surviving Bonferroni correction in 6 cases ( Table 5 ). Regions showing pronounced AEI largely differed between subjects. Repeat assays using freshly synthesised cDNA confirmed significant (p < 0.05) differences in allele ratios between the region showing most pronounced AEI and the region showing least AEI in 4 of the 6 subjects (#8, #11, #56 and #57). As for the assayed SNP in ZNF804A, when data from all subjects and regions were combined, there was a general trend for directional AEI at TCF4 exonic SNP rs8766 (p < 0.0001), suggesting linkage disequilibrium with a functional variant.
However, in contrast to our assay of ZNF804A, there was little suggestion that the extent of TCF4 AEI followed a common regional pattern, as no regional differences in cDNA ratios were observed when all subjects were combined (Kruskal Wallis χ2 = 11.5, d.f. = 8, p = 0.17). Instead, significant (p < 0.01) differences were seen between by guest on November 4, 2016 http://hmg.oxfordjournals.org/ Downloaded from genomic DNA and cDNA allele ratios derived from every assayed brain region, with the G-allele of rs8766 relatively over-expressed in each case.
The subjects showing significant regional differences in allelic expression (surviving correction for multiple tests) differed between gene assays, with the exception of 1 subject showing regional differences in both RGS4 and NOS1 and 2 subjects showing such differences in both AKT1 and TCF4. Regional differences were therefore seen in a large proportion of the assayed subjects (14 / 20), rather than arising from a few particular samples. None of the DNAse-treated RNA samples gave rise to a visible product on agarose in the absence of reverse-transcription, indicating that differences in allelic expression were not the result of residual genomic DNA contamination (which would artificially bias cDNA ratios towards the 1:1 genomic ratio).
DISCUSSION
Using measures of relative allelic expression across multiple brain regions, within individual subjects, we have shown that the effects of cis-variation on gene expression can significantly differ between sampled areas of the adult brain. Only by testing within individual subjects could we be certain that the genetic cis-regulatory variants were constant between brain regions. For all 5 assayed genes, we observed significant regional differences in allelic expression in multiple subjects, suggesting this to be a common phenomenon. In the case of ZNF804A, a robustly-supported susceptibility gene for schizophrenia 11, 12, 16 , we observed a general regional pattern of allelic expression at the assayed SNP. Our data therefore extend previous observations of tissue-specificity of allelic expression e.g. 4, [6] [7] [8] in showing that this can also differ between regions of the adult human brain. 9 All 5 assayed genes have been reported to show genetic association with neuropsychiatric illness [11] [12] [13] [14] [15] [16] . Previous evidence exists for common genotypic effects on the expression of all of these genes 12, 14, [16] [17] [18] , with the exception of TCF4 (a susceptibility gene for schizophrenia 15 which is mutated in Pitt-Hopkins syndrome 19, 10 then differentially sampled between brain regions. However, imprinting appears to affect only a small proportion of human genes 22 , and there is no previous evidence that any of the 5 genes assayed in this study are subject to such regulation. Recent evidence suggests that a significant proportion of human genes are subject to random epigenetic allele silencing that can persist in clonal cell lines 23 . However, this also appears an unlikely explanation for our findings, since the number of sampled cells from each region would presumably result in any purely random bias for either allele being cancelled out. Within subjects, we observed a general consistency in which allele was over-expressed, again arguing against a purely random mechanism. Recent studies have indicated that common allelic differences in DNA methylation are usually associated with DNA sequence variation 24, 25 . Moreover, there is evidence that such allele-specific methylation can differ between tissues 25 . Differences between brain regions in the extent of methylation at variable DNA sites may therefore provide an alternative explanation for our findings.
In the case of ZNF804A and TCF4, we observed a general consistency across subjects in which allele was relatively over-expressed, suggesting either that the assayed SNPs have direct effects on gene expression or (perhaps more likely) that they are in linkage disequilibrium with DNA variants of that effect. General AEI of ZNF804A in human brain tissue has recently been reported at an exonic SNP with which ours is likely to be in perfect linkage disequilibrium (r 2 = 1 in the HapMap CEU sample), and which is itself in strong linkage disequilibrium with the intronic SNP showing strongest association with schizophrenia 12 . It should be noted, however, that in a comparison between heterozygotes and homozygotes for the risk SNP, the authors found no difference in (cortical) allelic expression, leading to the conclusion that the risk SNP was not in itself responsible for AEI. In the present study, we have found that allelic expression of ZNF804A is generally pronounced in some brain regions and very little in others. In contrast, in our assay of TCF4, we observed similar levels of general AEI across all assayed brain regions. However, on the individual subject level, we found that, while there was directional AEI of TCF4 in all brain regions, the extent of this imbalance would frequently differ significantly (and reproducibly) between regions.
Given that there appears to be little consistency in the region(s) showing pronounced AEI across subjects, it is possible that there are multiple regionally-sensitive regulatory variants in TCF4, leading to individual differences. Alternatively, there may be a single cis-regulatory variant with differential effects on the many TCF4 transcripts known to exist, which are then differentially expressed / sampled between regions and subjects. Transcript-specific assays of allelic expression are likely to be informative for this and other genes assayed in the present study.
The human brain serves a wide range of functions, from physiological homeostasis to higher cognition. While multiple brain regions are typically recruited for any given function, it is clear that there exists a high degree of regional specialization. The effects of cis-regulatory variation are therefore likely to have distinct phenotypic consequences depending on where in the brain they are manifest. Our data show that such effects are often far more restricted than expression of the regulated gene per se.
Our demonstration of differential allelic expression across brain regions has important implications for studies of cis-regulatory variation in the brain. First, it highlights the caveat that it may not be possible to generalise findings to brain areas that have not been assayed. Second, it suggests that power to detect association between particular by guest on November 4, 2016 http://hmg.oxfordjournals.org/ Downloaded from gene variants and gene expression may be improved by careful matching of tissue samples. Third, it shows that specific regions of the brain where the effects of cisregulatory variants are manifest (or pronounced) can be delineated. Using such an approach, it should therefore be possible to define brain areas, and perhaps even cell populations, in which cis-regulatory variants conferring susceptibility to neuropsychiatric disease are active.
MATERIALS AND METHODS

Brain Samples
Experiments were carried out using post-mortem brain tissue from 20 unrelated All cDNA samples were diluted 1/7 prior to assay of allelic expression.
Allelic expression assays
Assays of relative allelic expression required that subjects were heterozygous for an SNP in exonic sequence, in order to distinguish and quantify RNA transcribed from each parental chromosome. Exonic SNP rs12476147 was used to assay ZNF804A, rs10759 to assay RGS4, rs1130233 to assay AKT1, rs1047735 to assay NOS1 and rs8766 to assay TCF4. Assayable heterozygotes were initially identified by genotyping genomic DNA from 64 control individuals for each of these polymorphisms. Assays of relative allelic expression were performed for each gene on a per-subject basis, with cDNA from all available brain regions from each subject Peak heights of allele-specific extended primers were determined using GeneMarker® software (SoftGenetics) and the ratio of the 2 peak heights calculated for each reaction. For each plate, the average ratio of allelic peak heights for genomic DNA was used as a correction factor for all allele ratios, since this can be assumed to reflect a perfect 1:1 ratio of the 2 alleles and can therefore be used to correct for any inequalities in allelic representation specific to each assay 2 . The above procedure was performed twice for each sample, giving a total of 4 corrected cDNA allele ratios for each brain region. For the additional 2 RT reactions per region from subjects showing significant regional differences in allelic expression in the first analysis, the above procedure was performed 4 times, giving a total of 8 corrected cDNA allele ratios for each repeated brain region.
Statistical Analyses
Statistical tests were performed using SPSS 15.0. cDNA allele ratios were initially compared between all assayed brain regions within each subject using Kruskal-Wallis tests. Derived p-values for each subject assay were corrected by the number of individual tests for each gene (i.e. subjects assayed) using Bonferroni correction. In subjects showing significant differences in cDNA ratios between brain regions Table 5 . Average TCF4 cDNA allele ratios at rs8766 in 10 brain regions from 7
subjects. Ratios are the average of 4 measures of each sample, corrected by the average allele ratio derived from concurrent assay of heterozygous genomic DNA.
Standard deviations are shown in parentheses. Blank cells correspond to samples that were unavailable for assay. P-values are given for Kruskal Wallis tests of differences in allelic expression across all assayed brain regions for each subject. P-values in bold are those that survived Bonferroni correction for 7 tests. See Table 1 legend for key to abbreviated brain regions.
